Jane Street’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $706K | Buy |
190,373
+49,494
| +35% | +$184K | ﹤0.01% | 3296 |
|
2025
Q1 | $455K | Sell |
140,879
-69,945
| -33% | -$226K | ﹤0.01% | 4059 |
|
2024
Q4 | $1.17M | Buy |
210,824
+65,312
| +45% | +$364K | ﹤0.01% | 2735 |
|
2024
Q3 | $1.57M | Buy |
145,512
+11,987
| +9% | +$130K | ﹤0.01% | 2752 |
|
2024
Q2 | $2.8M | Buy |
133,525
+104,014
| +352% | +$2.18M | ﹤0.01% | 2333 |
|
2024
Q1 | $940K | Buy |
29,511
+4,016
| +16% | +$128K | ﹤0.01% | 3292 |
|
2023
Q4 | $517K | Sell |
25,495
-21,429
| -46% | -$434K | ﹤0.01% | 4067 |
|
2023
Q3 | $597K | Buy |
46,924
+5,141
| +12% | +$65.4K | ﹤0.01% | 3421 |
|
2023
Q2 | $755K | Buy |
+41,783
| New | +$755K | ﹤0.01% | 3357 |
|
2023
Q1 | – | Sell |
-36,306
| Closed | -$806K | – | 5754 |
|
2022
Q4 | $806K | Buy |
+36,306
| New | +$806K | ﹤0.01% | 2873 |
|